Neurological Disease Researchers Confirm Link Between Adaptive Immune System and Alzheimer's Disease
By LabMedica International staff writers Posted on 06 Mar 2016 |
Image: Microglia (green) surround an amyloid plaque (blue) in the brain of an Alzheimer\'s disease mouse model. Endogenous mouse antibodies (red) associate with microglia in the brains of such mice and boost the microglia\'s ability to degrade plaques (Photo courtesy of Dr. Samuel Marsh, University of California, Irvine).
Using a novel immunodeficient mouse model that they had created, a team of neurological disease researchers demonstrated the link between the adaptive immune system and the development of Alzheimer's disease.
While neuroinflammation and activation of innate immunity are pathological hallmarks of Alzheimer’s disease (AD), very few studies have examined the impact of the adaptive immune system on the progression of AD. To clarify this matter, investigators at the University of California, Irvine (USA) generated an immunodeficient AD mouse model that lacked T-, B-, and natural killer (NK) cells.
They reported in the February 16, 2016, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that these "Rag-5xfAD" mice exhibited a greater than twofold increase in beta-amyloid (A-beta) pathology. Gene expression analysis of the brain implicated altered innate and adaptive immune pathways, including changes in cytokine/chemokine signaling and decreased Ig-mediated processes. Neuroinflammation was also greatly exacerbated in the Rag-5xfAD mice as indicated by a shift in microglial phenotype, increased cytokine production, and reduced phagocytic capacity.
In contrast, immune-intact 5xfAD mice exhibited elevated levels of nonamyloid reactive IgGs in association with microglia, and treatment of Rag-5xfAD mice or cultures of their microglial cells with preimmune IgG enhanced A-beta clearance. In addition, bone marrow transplantation studies in Rag-5xfAD mice revealed that replacement of these missing adaptive immune populations could dramatically reduce AD pathology.
"We were very surprised by the magnitude of this effect," said senior author Dr. Mathew Blurton-Jones, assistant professor of neurobiology and behavior at the University of California, Irvine. "We expected the influence of the deficient immune system on Alzheimer's pathology to be much more subtle. We know that the immune system changes with age and becomes less capable of making T- and B-cells, so whether aging of the immune system in humans might contribute to the development of Alzheimer's is the next big question we want to ask."
Related Links:
University of California, Irvine
While neuroinflammation and activation of innate immunity are pathological hallmarks of Alzheimer’s disease (AD), very few studies have examined the impact of the adaptive immune system on the progression of AD. To clarify this matter, investigators at the University of California, Irvine (USA) generated an immunodeficient AD mouse model that lacked T-, B-, and natural killer (NK) cells.
They reported in the February 16, 2016, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that these "Rag-5xfAD" mice exhibited a greater than twofold increase in beta-amyloid (A-beta) pathology. Gene expression analysis of the brain implicated altered innate and adaptive immune pathways, including changes in cytokine/chemokine signaling and decreased Ig-mediated processes. Neuroinflammation was also greatly exacerbated in the Rag-5xfAD mice as indicated by a shift in microglial phenotype, increased cytokine production, and reduced phagocytic capacity.
In contrast, immune-intact 5xfAD mice exhibited elevated levels of nonamyloid reactive IgGs in association with microglia, and treatment of Rag-5xfAD mice or cultures of their microglial cells with preimmune IgG enhanced A-beta clearance. In addition, bone marrow transplantation studies in Rag-5xfAD mice revealed that replacement of these missing adaptive immune populations could dramatically reduce AD pathology.
"We were very surprised by the magnitude of this effect," said senior author Dr. Mathew Blurton-Jones, assistant professor of neurobiology and behavior at the University of California, Irvine. "We expected the influence of the deficient immune system on Alzheimer's pathology to be much more subtle. We know that the immune system changes with age and becomes less capable of making T- and B-cells, so whether aging of the immune system in humans might contribute to the development of Alzheimer's is the next big question we want to ask."
Related Links:
University of California, Irvine
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples